OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) - MEDGENICS INC ownership

MEDGENICS INC's ticker is MDGN and the CUSIP is 58436Q203. A total of 67 filers reported holding MEDGENICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) ownership history of MEDGENICS INC
ValueSharesWeighting
Q2 2016$278,000,00050,0000.01%
Other shareholders
MEDGENICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,390,000$8,368,0003.50%
Broadfin Capital, LLC 3,045,306$18,333,0001.13%
Belmont Global Advisors, Inc. 65,000$391,0000.51%
QVT Financial LP 867,608$5,223,0000.29%
CARL DOMINO INC 34,134$205,0000.16%
Spark Investment Management LLC 77,400$465,0000.06%
WHITE PINE CAPITAL LLC 20,000$120,0000.05%
Alambic Investment Management, L.P. 11,220$68,0000.04%
Baker Brothers Advisors 765,000$4,605,0000.04%
HYMAN CHARLES D 15,143$91,0000.02%
View complete list of MEDGENICS INC shareholders